JeffreyMarcGelfandMD
Neurology • San Francisco, CANeuroimmunology/Multiple Sclerosis
Associate Professor of Clinical Neurology, UCSF Department of Neurology, UCSF Neuroinflammation and MS Center
Dr. Gelfand is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
San Francisco, CA 94143Phone+1 415-476-1489
Education & Training
University of California (San Francisco)Residency, Neurology, 2007 - 2010- University of California (San Francisco)Internship, Internal Medicine, 2006 - 2007
Harvard Medical SchoolClass of 2006
Certifications & Licensure
CA State Medical License 2008 - 2026
FL State Medical License 2016 - 2018- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis Start of enrollment: 2018 Nov 16
Publications & Presentations
PubMed
- 54 citationsReduced contrast sensitivity among older women is associated with increased risk of cognitive impairment.Michael E. Ward, Jeffrey M. Gelfand, Li-Yung Lui, Yvonne Ou, Ari J. Green
Annals of Neurology. 2018-04-01 - 23 citationsMigraine and multiple sclerosis: Epidemiology and approach to treatmentAmy A. Gelfand, Jeffrey M. Gelfand, Peter J. Goadsby
Multiple Sclerosis and Related Disorders. 2013-04-01 - 10 citationsDetection of Neoplasms by Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid.Wei Gu, Andreas M. Rauschecker, Elaine Hsu, Kelsey C. Zorn, Yasemin D. Sucu
JAMA Neurology. 2021-11-01
Journal Articles
- Chronic Meningitis Investigated via Metagenomic Next-Generation SequencingJonathan H Blum, Luke Strnad, Leonard H Calabrese, John P Betjemann, Maulik P Shah, Felicia C Chow, Mark P Gorman, John E Greenlee, Michael R Wilson, Megan B Richie, W..., JAMA
Authored Content
- Risk of Neuroinflammatory Adverse Events with Tumor Necrosis Factor Inhibitor TreatmentMay 2020
Press Mentions
FSR Expands Scientific Advisory Board to Improve Research, CareSeptember 10th, 2024
Allergy Drug Improves Function in Patients with Chronic Injury from Multiple SclerosisOctober 12th, 2017
Potential Prognostic Biomarker for Clinically Isolated SyndromeJanuary 6th, 2017- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
